11.02.15
The worldwide market for prescription dermatological drugs exceeded $21 billion last year, growing 7.9% from 2013 to 2015, according to Kalorama Information. Driving forces include growth and aging of the population, new products and technologies, and focus on lifestyle treatments that improve the effects of aging and damage to the skin. Sales of prescription acne and rosacea reflected a slower growth rate because many of the drugs are older and have lost patent protection.